Mindbloom Launches Remote-Enabled Psychedelic Therapy In California To Meet Growing Demand

Share Article

Federal administration greenlights expanded telehealth services to reduce COVID-19 exposure

Mindbloom, a New York City-based consumer mental health and wellbeing company, has announced it will begin offering remote psychedelic therapy services to residents in the state of California this week. The company currently offers psychiatric clinician-supervised ketamine therapy to treat depression and anxiety to clients in New York, New Jersey, Nevada, Pennsylvania, and Florida with affordable and accessible pricing starting at $150 - $250 per session.

With headquarters on New York City’s Fifth Avenue, Mindbloom lifted its requirement for new clients to begin their journey with an in-person visit in March, converting to a full telehealth model in response to federal mandates for Americans to practice social distancing and limit unnecessary virus exposure.

Said Mindbloom Founder and CEO, Dylan Beynon, “As the COVID-19 pandemic escalates in the U.S., conditions for anxiety and depression have never been higher. Our partner clinicians have felt the call to service in this time of crisis. Our team has worked tirelessly to keep up with the demand for safe, accessible and affordable psychedelic medicine treatments.”

Using Mindbloom’s online platform, clients receive personalized, remotely-facilitated psychedelic therapy programs and ongoing virtual support from licensed psychiatric clinicians and trained guides. From initial video consultations to post-treatment 1:1 virtual integration sessions, Mindbloom clients are supported and supervised every step of the way.

How It Works:

  • Following an online survey to assess qualifying symptoms such as anxiety and depression, new clients consult with a licensed psychiatric clinician over video.
  • Ketamine tablets are prescribed and delivered to qualifying clients’ homes.
  • The first therapy session is scheduled; each session requires an in-person peer monitor to be present for the duration of the session.
  • A virtual provider prepares the client and peer monitor ahead of the session and remains available on-demand throughout the session.
  • Audioscapes and personalized psychedelic therapy content is available through Mindbloom’s web-based online platform to enhance the at-home experience.
  • Following each session, virtual providers are available to provide 1:1 integration support.

Said Mindbloom Medical Director Dr. Leonardo Vando, “We are fortunate to be in the position to accelerate the roll-out of our remote ketamine therapy programs in response to one of the greatest public health challenges Americans have ever faced.” He added, “Mindbloom began piloting remote treatment protocols several months prior to the onset of COVID-19, and we’ve safely and successfully facilitated over 500 remote sessions with overwhelmingly positive client outcomes.”

Mindbloom was established to increase Americans’ access to affordable, effective, and science-backed therapeutic experiences designed by leaders in the fields of psychiatry and psychedelic medicine. Founded by tech entrepreneur Dylan Beynon, designed by one of America’s foremost psychedelic medicine experts Dr. Casey Paleos, and clinically overseen by leading psychiatrist Dr. Leonardo Vando, Mindbloom’s initial offering is guided ketamine therapy affordably priced at $150 - $250 per session.

For more information about Mindbloom’s remote treatment options, safety precautions, or how to request a new client consultation, visit http://www.mindbloom.co

About Mindbloom, Inc.
Mindbloom is America’s leading destination for cutting-edge, science-backed approaches to achieving and maintaining optimal mental health and wellbeing through psychedelic medicine. Founded in New York City by seasoned tech entrepreneur Dylan Beynon, Mindbloom brings clinicians, researchers and technologists together to deliver guided ketamine therapy with supportive, thoughtfully designed, hospitality-inspired experiences. Treatment protocols are overseen by Medical Director and board certified psychiatrist Dr. Leonardo Vando and designed by Scientific Director Dr. Casey Paleos, a pioneer in psychedelic research and treatment. Mindbloom’s mission is to transform lives today to transform the world tomorrow by increasing access to transformational treatments that help its clients heal, grow, and expand their human potential.

Press Inquiries:
press@mindbloom.co

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dylan Beynon
Mindbloom
+1 (929) 274-0518
Email >
Visit website

Media